obtained her BSc in Pharmacy in 2010 (University of the Basque Country) and completed a master’s degree in Pharmacology (University of the Basque Country) in 2011. She obtained an international PhD in Pharmacology in 2014 also in the University of the Basque Country, including a 3-month stay with the Clinical Pharmacy Group at Saarland University (Germany). Her PhD project, focused on paediatric modeling, was part of a collaboration between the Applied Pharmacometric group at the University of the Basque Country and Dynakin, a spin-off born from this group in 2004. Esther has since then formed integral part of Dynakin’s DMC department as a Consulting Associate having participated in projects to resolve pre- and post-submission concerns, especially on bioequivalence hurdles, with a strong clinical and regulatory component. She is one of Dynakin´s pediatric ontogenic MBDD based scaling and design experts having authored significant research on that field. Esther also has experience in clinical trial design and protocol preparation and provides regulatory and modeling support to other departments within the company.